Perfosfamide

Perfosfamide, or 4-hydroperoxycyclophosphamide (trade name Pergamid) was an experimental drug candidate for blood cancers that was rejected by the FDA in 1993 and never reached the market.
Wikipedia contributors, "Perfosfamide", Wikipedia, revision 1365464348, retrieved 20 November 2026, source, CC BY-SA 4.0.